The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Fasinex Super 19.5% w/v Oral Suspension

19.5 percent weight/volume Oral suspension

Elanco GmbHVPA22020/005/001

Main Information

Trade NameFasinex Super 19.5% w/v Oral Suspension
Active SubstancesTriclabendazole
Levamisole hydrochloride
Strength19.5 percent weight/volume
Dosage FormOral suspension
Licence HolderElanco GmbH
Licence NumberVPA22020/005/001

Group Information

ATC CodeQP52A ANTHELMINTICS
Therapeutic ClassEndoparasiticide
SpeciesCattle

Status

Authorised/WithdrawnAuthorised
Licence Issued21/10/2016
Legal StatusLM: Licensed Merchant as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back